Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome-Reference-Cited by-同舟云学术

Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome

Published:2000-07 Issue:1 Volume:33 Page:43-48
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Uriz Juan,Ginès Pere,Cárdenas Andrés,Sort Pau,Jiménez Wladimiro,Salmerón Juan Manuel,Bataller Ramón,Mas Antoni,Navasa Miquel,Arroyo Vicente,Rodés Juan

Publisher

Elsevier BV

Subject

Hepatology

Reference18 articles.

1. Hepatorenal syndrome;Ginès;J Am Soc Nephrol,1999

2. Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion;Guevara;Hepatology,1998

3. Long-term therapy and retreatment of hepatorenal syndrome type I with ornipressin and dopamine;Gülberg;Hepatology,1999

4. Fachinformation: Glycylpressin R, Terlipressin Acetate. Kiel: Ferring Arzneimittel GmbH; 1996

5. Hepatorenal syndrome: long term treatment with terlipressin as a bridge to liver transplantation;Ganne-Carrié;Dig Dis Sci,1996

Cited by 340 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Renal Complications in Portal Hypertension;Clinics in Liver Disease;2024-08

2. Long-Circulating Vasoactive 1,18-Octadecanedioic Acid–Terlipressin Conjugate;ACS Pharmacology & Translational Science;2024-04-30

3. Hepatorenal Syndrome in Cirrhosis;Gastroenterology;2024-04

4. Terlipressin in the management of adults with hepatorenal syndrome-acute kidney injury (HRS-AKI);Expert Review of Gastroenterology & Hepatology;2023-10-27

5. Hepatorenal syndrome: Current concepts and future perspectives;Clinical and Molecular Hepatology;2023-10-01